PRMT5 and cancer: Despitethe genetic evidence for a synthetic lethal relationshipbetween PRMT5 and MTAP deletion, the first generationof PRMT5 inhibitors that were developed do not demonstrate selectivityfor MTAP-null cancer cell lines (Figure 1A and 1B).